| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |